Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Liberty Analyzer WBC System: Reference Interval Study

NCT: NCT07031882 · SUSPENDED

NCT IDNCT07031882
StatusSUSPENDED
Start Date2026-03-19
Completion2026-09-30
SponsorEntia Ltd (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to establish the reference intervals for WBC and granulocytes for the Liberty Analyzer WBC System.

Frequently Asked Questions

What is Liberty Analyzer WBC System: Reference Interval Study?

Liberty Analyzer WBC System: Reference Interval Study is a clinical trial registered under NCT07031882. Current status: SUSPENDED.

What is the status of NCT07031882?

The current status of NCT07031882 (Liberty Analyzer WBC System: Reference Interval Study) is: SUSPENDED.

When did Liberty Analyzer WBC System: Reference Interval Study start?

Liberty Analyzer WBC System: Reference Interval Study started on 2026-03-19.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑